
Since 2013 we have been sharing our understanding on key issues with friends and clients via our Insider’s Insights. Earlier releases have addressed subjects ranging from clinical study design to designing professional posters. This knowledge has been distilled from our 18 years working in the industry. Writing these documents is great fun for our team, allowing them to explore just how much they have learned. They also get the benefits of sharing these key learnings with their peers and getting encouraging feedback thanking them for their insights.
The experience is particularly sweet when appreciation turns into action. We received some great recognition that we wanted to share it with everyone. After the distribution of a recent Insider’s Insight entitled ‘Ready! Aim! Fire! An Insider’s Insight to Targeted Journal Selection’, the Journal of Cardiovascular Endocrinology kindly asked us to convert the document into a manuscript that could be shared with their readership.
It was great to see that the open access manuscript has been published online and can be downloaded [1]. I should also add that you can still download the original article (along with other articles) from our Insider’s Insight page [2].
We know that a high proportion of manuscripts are rejected by their author's first-choice journal. The aim of our work was to summarise published advice on getting published in the right journal. We only found one article that described a comprehensive model for submission decision-making. Identification of appropriate candidate journals by various web-based applications was erratic, with the Jane database providing the most robust suggestions. Our work confirms that little attention has been focused in the scientific literature on the mechanisms that authors use to select a journal for their work. We conclude that scientists for the most part seem to have a good sense of where their papers are most likely to be accepted. Beyond ensuring that a manuscript fulfils all the target journal's requirements, the literature suggests that it is important to have an objective view of the scientific contribution or 'value' of your work.
References


20th April 2023
- Tim Hardman
Every year, a huge amount of scientific data is released. It's out there, but how do you find it?
4th April 2023
- Tim Hardman
1st July 2013
- Tim Hardman
9th August 2016
- Tim Hardman
15th August 2017
- Tim Hardman
24th August 2016
- Tim Hardman
12th February 2014
- Tim Hardman
1st October 2018
- Tim Hardman
23rd April 2019
- Tim Hardman
18th March 2021
- Tim Hardman
19th October 2018
- Tim Hardman
11th September 2018
- Tim Hardman
3rd March 2015
- Tim Hardman
11th May 2023
- Tim Hardman
Investigator sites are very important to clinical studies because they make sure that new drugs are safe and work well.
6th December 2019
- Tim Hardman
21st December 2020
- Tim Hardman
1st September 2015
- Tim Hardman
29th March 2019
- Tim Hardman
30th March 2017
- Tim Hardman
17th July 2017
- Tim Hardman
20th September 2016
- Tim Hardman
31st January 2020
- Tim Hardman
We all need heroes - people who can champion our cause - helping the world to understand our rationale
2nd March 2021
- Tim Hardman
19th June 2018
- Tim Hardman
Experience at Niche has taught us that clinical study protocols are born in the white-hot fire
9th May 2017
- Tim Hardman
28th March 2025
- Tim Hardman
1st August 2012
- Tim Hardman
1st July 2019
- Tim Hardman
11th September 2015
- Tim Hardman
13th December 2018
- Tim Hardman
4th May 2018
- Tim Hardman
25th February 2021
- Tim Hardman
8th April 2019
- Tim Hardman
15th April 2019
- Tim Hardman
3rd February 2022
- Tim Hardman
The UK's world-class human challenge study gives us new information about SARS-CoV-2 cases that were mild in 36 healthy.
4th June 2020
- Tim Hardman
4th February 2014
- Tim Hardman
5th April 2017
- Tim Hardman
14th February 2022
- Tim Hardman
12th March 2012
- Tim Hardman
13th December 2016
- Tim Hardman
2nd November 2023
- Tim Hardman
11th November 2015
- Tim Hardman
3rd July 2019
- Tim Hardman
20th April 2016
- Tim Hardman
12th July 2022
- Tim Hardman
9th May 2017
- Tim Hardman
20th June 2022
- Tim Hardman
I am continually reminded that I must work toward better relationships with my sons than the one I had with my dad.
27th February 2019
- Tim Hardman
2nd June 2015
- Tim Hardman
31st March 2021
- Tim Hardman
21st December 2018
- Tim Hardman
27th January 2023
- Tim Hardman
Concerns about readiness of the European Medicines Agency’s (EMA) Clinical Trials Information System persist as the.
15th February 2018
- Tim Hardman
7th July 2013
- Tim Hardman
26th February 2019
- Tim Hardman
14th February 2024
- Tim Hardman
We recently encouraged writers (of all kinds) in our recent Insider’s Insight to experiment with large language.
14th March 2017
- Tim Hardman
3rd August 2014
- Tim Hardman
28th August 2018
- Tim Hardman
7th June 2022
- Tim Hardman
11th May 2018
- Tim Hardman
Our team are exploring different and novel ways for young people to enter the pharmaceutical industry.
19th May 2023
- Tim Hardman
7th October 2012
- Tim Hardman
12th November 2016
- Tim Hardman
30th April 2018
- Tim Hardman
18th April 2019
- Tim Hardman
26th August 2015
- Tim Hardman
31st May 2023
- Tim Hardman
Advisory board meetings are often used to address perceived knowledge gaps and build consensus.
27th April 2023
- Tim Hardman
19th November 2018
- Tim Hardman
The proceedings of the Association for Human Pharmacology in the Pharmaceutical Industry (AHPPI)
27th July 2023
- Tim Hardman
Investigator-Initiated Clinical Trials (IITs) are clinical studies led by academic researchers or clinicians
12th May 2020
- Tim Hardman
9th February 2021
- Tim Hardman
16th May 2023
- Tim Hardman
Scientific knowledge should be accessible to all and if you are those communicating science
8th September 2020
- Tim Hardman
6th September 2018
- Tim Hardman
4th May 2020
- Tim Hardman
28th February 2019
- Tim Hardman
ive years ago I was lucky enough to be involved in a project that resulted in publications
9th October 2017
- Tim Hardman
4th July 2018
- Tim Hardman
17th January 2018
- Tim Hardman
6th January 2023
- Tim Hardman
2nd July 2020
- Tim Hardman
22nd January 2019
- Tim Hardman
31st October 2021
- Tim Hardman
In the past, Halloween has meant the end of the crop and the start of the dark, cold winter.
1st April 2019
- Tim Hardman
25th April 2019
- Tim Hardman
16th June 2018
- Tim Hardman
8th January 2017
- Tim Hardman
Searching the literature can take various forms, ranging from a quick scan of recent publications
24th February 2020
- Tim Hardman
Finding the best vehicle in which to publish your research findings is a perennial challenge.
24th March 2025
- Tim Hardman
25th October 2019
- Tim Hardman
15th September 2015
- Tim Hardman
23rd May 2023
- Tim Hardman
I have never been great at conferences. People don’t believe me but I am painfully shy and far too worried about what.
31st January 2017
- Tim Hardman
14th April 2012
- Tim Hardman
16th April 2018
- Tim Hardman
18th May 2023
- Tim Hardman
Have you seen our latest Insider's Insight on Case Reports? Once a staple of medical journals,
14th August 2018
- Tim Hardman
The largest pharmaceutical companies not surprisingly rely on the largest contract research organizations
Get our latest news and publications
Sign up to our news letterResources
Contact us
Address
Niche Science & Technology
Unit 26 Falstaff House
Bardolph Road
Richmond TW9 2LH
United Kingdom
Regular Updates

